Teladoc Health, Inc. (NYSE:TDOC) Shares Bought by Himension Capital Singapore PTE. LTD.

Himension Capital Singapore PTE. LTD. lifted its position in shares of Teladoc Health, Inc. (NYSE:TDOC) by 244.3% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 205,941 shares of the health services provider’s stock after buying an additional 146,131 shares during the quarter. Himension Capital Singapore PTE. LTD. owned approximately 0.12% of Teladoc Health worth $1,872,000 at the end of the most recent quarter.

A number of other large investors have also recently added to or reduced their stakes in the business. Vanguard Group Inc. lifted its holdings in shares of Teladoc Health by 5.9% in the fourth quarter. Vanguard Group Inc. now owns 18,463,155 shares of the health services provider’s stock valued at $167,830,000 after purchasing an additional 1,029,829 shares in the last quarter. Geode Capital Management LLC increased its position in Teladoc Health by 0.6% during the fourth quarter. Geode Capital Management LLC now owns 3,947,831 shares of the health services provider’s stock worth $35,894,000 after buying an additional 22,664 shares in the last quarter. Charles Schwab Investment Management Inc. raised its holdings in shares of Teladoc Health by 18.7% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 2,443,713 shares of the health services provider’s stock worth $22,213,000 after acquiring an additional 384,528 shares during the last quarter. Robeco Institutional Asset Management B.V. lifted its position in shares of Teladoc Health by 21.8% in the fourth quarter. Robeco Institutional Asset Management B.V. now owns 700,166 shares of the health services provider’s stock valued at $6,365,000 after acquiring an additional 125,111 shares in the last quarter. Finally, Nisa Investment Advisors LLC lifted its holdings in Teladoc Health by 20,936.8% in the 4th quarter. Nisa Investment Advisors LLC now owns 426,206 shares of the health services provider’s stock valued at $3,874,000 after purchasing an additional 424,180 shares in the last quarter. 76.82% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several equities research analysts have recently issued reports on TDOC shares. Needham & Company LLC restated a “hold” rating on shares of Teladoc Health in a report on Thursday, February 27th. Oppenheimer dropped their price objective on shares of Teladoc Health from $14.00 to $12.00 and set an “outperform” rating for the company in a research note on Friday, January 24th. The Goldman Sachs Group dropped their price target on shares of Teladoc Health from $16.00 to $13.00 and set a “buy” rating for the company in a research report on Monday, March 3rd. Piper Sandler decreased their price target on shares of Teladoc Health from $13.00 to $12.00 and set an “overweight” rating on the stock in a report on Thursday, February 27th. Finally, Royal Bank of Canada upped their price target on Teladoc Health from $11.00 to $12.00 and gave the stock an “outperform” rating in a research note on Friday, January 24th. Eleven analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. According to data from MarketBeat.com, Teladoc Health currently has a consensus rating of “Hold” and a consensus price target of $11.26.

Teladoc Health Stock Down 3.6 %

TDOC stock opened at $7.26 on Friday. The firm has a market cap of $1.26 billion, a price-to-earnings ratio of -1.26 and a beta of 1.73. Teladoc Health, Inc. has a 1-year low of $6.76 and a 1-year high of $15.21. The firm has a fifty day moving average price of $10.14 and a two-hundred day moving average price of $9.77. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.73 and a quick ratio of 1.69.

Teladoc Health (NYSE:TDOC) last announced its quarterly earnings results on Wednesday, February 26th. The health services provider reported ($0.28) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.21) by ($0.07). Teladoc Health had a negative net margin of 37.91% and a negative return on equity of 10.06%. The firm had revenue of $640.49 million for the quarter, compared to analyst estimates of $639.44 million. Research analysts predict that Teladoc Health, Inc. will post -1.16 EPS for the current year.

Insider Activity

In other news, insider Adam C. Vandervoort sold 11,011 shares of the stock in a transaction on Thursday, March 20th. The stock was sold at an average price of $8.42, for a total value of $92,712.62. Following the completion of the transaction, the insider now owns 64,308 shares of the company’s stock, valued at approximately $541,473.36. This represents a 14.62 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Corporate insiders own 0.95% of the company’s stock.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.